Photo of Chrissy Houlahan
D United States House · District 6 · Pennsylvania On the 2026 ballot

Rep. Chrissy Houlahan

Compare
Total votes
2,837
all sessions
Attendance
98%
53 missed
Near the chamber average
With party
95%
of cast votes
Lower than 76% of chamber peers
Bipartisan score
2%
crosses aisle rarely
Higher than 75% of chamber peers
Sponsored
1,247
bills & resolutions
Near the chamber average
Committees
6
assignments
1,247 bills and resolutions

Sponsored bills

Total
1,247
Primary
85
Co-sponsor
1,162
This page
1,247
matching current filters
Co-sponsor HR 2290
Passed · Indiana House · Co-sponsor
World War II Women's Memorial Location Act

Maddy summaryThis bill authorizes the placement of a memorial honoring women who supported the U.S. war effort during World War II (including those working as pilots, engineers, and in factories) on federal land in Washington, D.C. It specifies two locations: Area I on the National Mall map or the National Mall Reserve, as defined in existing law. The memorial was previously authorized by Section 702 of the 2023 Consolidated Appropriations Act (Public Law 117-328), and this bill clarifies its permitted locations.

Passed Dec 10, 2025 1 co-sponsor
Co-sponsor HR 1461
Passed · Indiana House · Co-sponsor
To designate the facility of the United States Postal Service located at 521 Thorn Street in Sewickley, Pennsylvania, as the "Mary Elizabeth 'Bettie' Cole Post Office Building".

Maddy summaryHR 1461 designates the U.S. Postal Service facility at 521 Thorn Street in Sewickley, Pennsylvania, as the "Mary Elizabeth 'Bettie' Cole Post Office Building." The bill updates all official references to this specific post office location to reflect the new name. This is a ceremonial naming resolution honoring Mary Elizabeth "Bettie" Cole, with no new policies, funding, or operational changes to the postal facility.

Passed Dec 10, 2025 1 co-sponsor
Co-sponsor HR 6533
In committee · Indiana House · Co-sponsor
Military in Law Enforcement Accountability Act

Maddy summaryThe Military in Law Enforcement Accountability Act requires the President to submit detailed justification to Congress before the military provides support to civilian law enforcement, including specific budget, timeline, and funding details, with a 30-day limit on such support unless Congress approves a longer period through a specific joint resolution process. It prohibits Department of Defense personnel (including military members) from holding civilian law enforcement positions concurrently, with limited exceptions for reserve members who must recuse during active duty. The bill also removes the military's authorization to deploy for "civil disturbances" without the new approval process and establishes a private right for individuals or governments to sue the federal government for violations. This directly affects the Department of Defense, military support to local police agencies, and DoD personnel's dual employment policies.

In committee Dec 9, 2025 1 co-sponsor
Primary HR 6490
In committee · Indiana House · Lead sponsor
To direct the Secretary of Defense to establish a pilot program to provide certain members of the Armed Forces with timely and relevant information via text message, and for other purposes.

Maddy summaryHR 6490 establishes a pilot program (the "Push-Text Initiative") for members of the Marine Corps stationed at installations in Okinawa, Japan, and their adult dependents. The program automatically enrolls eligible participants using their provided contact information (with an opt-out option) to send text messages containing specific, timely information. Key topics covered include military spouse employment resources, childcare services, TRICARE benefits, and updates on DOD policies affecting service members and dependents. The Secretary of Defense must report on the program's implementation, participation, costs, and potential for Department-wide expansion by October 2027.

In committee Dec 5, 2025 0 co-sponsors
Co-sponsor HR 6423
In committee · Indiana House · Co-sponsor
HELP Copays Act

Maddy summaryHR 6423, the HELP Copays Act, requires health insurance plans and coverage to count financial assistance from non-profits or drug manufacturers toward patient cost-sharing limits like deductibles and copayments. This directly affects patients enrolled in health insurance who receive such assistance for prescription drugs, ensuring the help they get reduces their out-of-pocket costs faster. The bill amends key health laws to mandate that these payments are included when calculating whether a patient has met their deductible or copayment threshold. The change applies to all prescription drugs, including specialty drugs and those subject to prior authorization, but does not alter how insurers manage drug access through tools like step therapy. It takes effect for plan years starting in 2026.

In committee Dec 4, 2025 1 co-sponsor
Co-sponsor HRES 925
In committee · Indiana House · Co-sponsor
Condemning the Government of Iran's state-sponsored persecution of the Baha'i minority in Iran and the continued violation of the Universal Declaration of Human Rights and the International Covenant on Civil and Political Rights.

Maddy summaryHRES 925 is a non-binding resolution condemning the Iranian government's ongoing persecution of the Baha'i religious minority. It directly affects Baha'is in Iran, who face systemic discrimination, imprisonment, denial of education and employment, and violence due to their faith. The resolution calls on Iran to immediately release Baha'i prisoners, end hate propaganda targeting them, and reverse policies banning their access to education and jobs. It also urges the U.S. President and Secretary of State to demand Iran's compliance and use existing sanctions authorities against officials responsible for human rights abuses against Baha'is.

In committee Dec 3, 2025 1 co-sponsor
Co-sponsor HR 6383
In committee · Indiana House · Co-sponsor
Brandon Act Training and Protocol Act

Maddy summaryHR 6383, the Brandon Act Training and Protocol Act, requires the Department of Defense to create a strategic plan addressing mental health and suicide prevention among military members. The plan mandates uniform protocols for members seeking mental health help on their own and standardized training for commanders, medical staff, and enlisted leaders on recognizing distress, supporting referrals, and responding appropriately. It also establishes a certification process to confirm personnel complete required training. This bill directly affects all members of the Armed Forces through improved mental health access and support, while requiring commanders and medical personnel to implement new protocols. The focus is on concrete policy changes to standardize mental health services within the military.

In committee Dec 3, 2025 1 co-sponsor
Co-sponsor HR 6400
In committee · Indiana House · Co-sponsor
Rx ACCESS Act

Maddy summaryThe Rx ACCESS Act improves prescription drug access for TRICARE beneficiaries, including military service members, retirees, and their families, by establishing fair reimbursement standards for pharmacies and expanding medication choice. It requires pharmacies to be reimbursed at actual drug costs (or the national average drug cost for certain medications) plus a standard dispensing fee, while banning hidden fees like point-of-sale charges. Starting October 1, 2026, beneficiaries can choose how they receive non-generic medications for ongoing health conditions. The law also mandates annual audits to verify reimbursement fairness and ensure pharmacy networks provide accessible care, especially in rural and underserved areas.

In committee Dec 3, 2025 1 co-sponsor
Co-sponsor HR 6412
In committee · Indiana House · Co-sponsor
Independence Investment Fund Act

Maddy summaryThe Independence Investment Fund Act (HR 6412) establishes a Treasury Department fund to invest in U.S. companies developing critical and emerging technologies, prioritizing biotechnology. The fund makes seed-to-mid-stage equity investments (typically $1 million to $10 million per company) to strengthen national security and economic security while aiming for financial self-sustainability through returns. It requires an advisory board to set investment strategy and a supervisory board to approve investments, with annual reporting to Congress on progress toward goals. The bill authorizes $975.5 million for fiscal year 2025 (including $300 million for biotech), directing investments away from foreign entities of concern and toward companies vulnerable to adversarial foreign capital.

In committee Dec 3, 2025 1 co-sponsor
Co-sponsor HR 1262
Passed · Indiana House · Co-sponsor
Mikaela Naylon Give Kids a Chance Act

Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research.  Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research.  The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)

Passed Dec 2, 2025 1 co-sponsor
Showing 131 to 140 of 1,247 bills
Previous 1 … 13 14 15 … 125 Next